ngn-401
ngn-401: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Neurogene Inc. (NGNE) | Phase 3 |
Clinical Trials (1)
A Baseline-Controlled, Open-Label, Multicenter, Single-Arm, Pivotal Study to Evaluate the Efficacy, Safety, and Tolerability of NGN-401 in Subjects With Rett Syndrome (Embolden)
Frequently asked questions
Who is developing ngn-401?
ngn-401 is being developed by Neurogene Inc..
How many clinical trials involve ngn-401?
BioSniper tracks 1 clinical trial involving ngn-401.
Get deeper analysis on ngn-401
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis